Krebs Biochemicals Reports Rs 532.43 Crore Loss in Q1, Appoints New MD & CEO Aug 08, 2025
Krebs Biochemicals Appoints New MD & CEO, Announces Q1 Results Aug 07, 2025
Krebs Biochemicals Announces Q1 Results and Leadership Transition Aug 07, 2025
More news about Krebs Biochemicals & Industries
25Jul 25
Krebs Biochemicals & Industries' MD & CEO Jitendra Shah Steps Down
Jitendra Shah, Managing Director, CEO, and Director of Krebs Biochemicals & Industries Limited, has announced his resignation effective August 7, 2025, citing personal reasons. The resignation letter was submitted on July 25, 2025. The company has informed BSE Limited and the National Stock Exchange of India Ltd about this development. No successor has been announced yet, with the board expected to address the transition in the upcoming meeting on August 7, 2025.